文献速递小儿神经外科与脑积水神经重症

儿童脑脊液分流管真菌感染:系统文献综述与病例报告

Fungal Infections of Cerebrospinal Fluid Shunt in Pediatric Patients: A Systematic Literature Review With a Case Report.
PubMed 文献 · World Neurosurg · 2025-10-15

该系统综述遵循PRISMA指南,检索多个数据库至2024年9月6日,纳入26项研究共38例儿童患者,加上本机构1例共分析39例。念珠菌属最常见(76.92%),脑脊液培养确诊77.78%,两性霉素B单药治疗最常见(55.56%),复发率和死亡率均为10.81%。

要点

  • 儿童脑脊液分流管真菌感染以念珠菌属为主,白色念珠菌最常见。
  • 脑脊液培养确诊率约77.78%,两性霉素B是最常用单药治疗。
  • 复发率和死亡率均为10.81%,需广谱治疗策略。

核心结论

  • 儿童脑脊液分流管真菌感染治疗挑战大,需实施广谱治疗策略以获得成功结局。
  • 持续性真菌感染时可能需要脑室内和鞘内抗真菌药物给药。

研究设计与样本

  • 系统综述遵循PRISMA指南,检索PubMed、Scopus、Web of Science、Mendeley和Cochrane Library数据库,从建库至2024年9月6日。
  • 纳入26项研究报告38例儿童患者,加上本机构1例,共分析39例患者。

主要发现

  • 念珠菌属是最常见病原体(76.92%),白色念珠菌最流行(58.97%)。
  • 脑脊液培养确诊感染占77.78%。
  • 两性霉素B是最常用单药抗真菌药(55.56%)。
  • 给药途径主要为静脉(92.86%),脑室内和鞘内给药分别占27.59%和20.00%。
  • 5.13%患者接受真菌赘生物切除,复发率和死亡率均为10.81%。

关键数值与推荐

  • 脑脊液分流管感染影响5%-15%的患者,主要由细菌病原体引起,真菌罕见。
  • 脑脊液培养确诊真菌感染占77.78%。
  • 两性霉素B单药治疗占55.56%,静脉给药占92.86%,脑室内给药占27.59%,鞘内给药占20.00%。
  • 复发率和死亡率均为10.81%。

临床怎么用

  • 儿童脑脊液分流管感染应考虑到真菌可能,尤其细菌培养阴性时。
  • 两性霉素B是常用单药,静脉给药为主,必要时可脑室内或鞘内给药。
  • 持续性真菌感染可能需要脑室内和鞘内抗真菌药物给药。

局限性

  • 基于病例报告和病例系列的系统综述,证据等级较低。
  • 样本量小(39例),可能存在发表偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The standard treatment of hydrocephalus consists of the implantation of a cerebrospinal fluid (CSF) shunt. Infection of the CSF shunts affects 5%-15% of the patients, primarily due to bacterial pathogens, with rare cases involving fungi. This study aimed to systematically review the clinical characteristics, diagnostic approaches, treatment strategies, and outcomes of fungal CSF shunt infections in children. METHODS: A systematic review was conducted according to the PRISMA guidelines. PubMed, Scopus, Web of Science, Mendeley, and Cochrane Library databases were searched for studies on fungal CSF shunt infection in children, published from inception until 6 September 2024. RESULTS: A total of 26 studies reporting on 38 pediatric patients were found eligible, including our institutional case; a total of 39 patients were analyzed. Candida genus remained the most common causative agent (76.92%), with Candida albicans being the most prevalent (58.97%). CSF culture confirmed the infection in 77.78% of the cases. Amphotericin B was the most frequently used antifungal agent in monotherapy (55.56%). The primary route of administration was intravenous (92.86%), while intraventricular and intrathecal administration were used in 27.59%, and 20.00% of patients, respectively. Notably, 5.13% patients underwent fungal vegetation removal. Both the recurrence and the mortality rates were 10.81%. CONCLUSIONS: Fungal CSF shunt infections pose significant therapeutic challenges, necessitating the implementation of a broad treatment strategy to achieve successful outcomes. Intraventricular and intrathecal antifungal drug administration may become necessary, especially in persistent fungal infections.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kardas N, Wyroba N, Sordyl R, et al. Fungal Infections of Cerebrospinal Fluid Shunt in Pediatric Patients: A Systematic Literature Review With a Case Report. World Neurosurg. 2025. PMID: 41106546. doi:10.1016/j.wneu.2025.124567

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。